Skip to content

Clinical trials

Lymphoma, Large-Cell, Anaplastic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20092
20101
20132
20151
20161
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Novartis Pharmaceuticals2
Samsung Medical Center2
Chonbuk National University Hospital1
Hoffmann-La Roche1
Pfizer1
Seagen Inc.1
Singapore General Hospital1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic12
Immunoblastic Lymphadenopathy5
Lymphoma4
Lymphoma, T-Cell4
Granuloma, Plasma Cell3
Hodgkin Disease3
Lymphoma, Extranodal NK-T-Cell3
Lymphoma, Non-Hodgkin3
Lymphoma, T-Cell, Cutaneous3
Blast Crisis2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.